An Ebola outbreak in North Kivu has recorded a 66% fatality rate and the World Health Organisation has said the number of cases is likely to rise. Efforts to tackle the scourge are being hampered by disruption from armed militia groups. Misinformation about the outbreak is also hindering support. Wellcome Trust Head Jeremy Farrar said it was “remarkable” that the disease hadn't spread further but the numbers were “frightening” and their increase “terrifying”. Health officials now have a supply of Merck’s experimental V920 drug, which though effective, is in limited supply.
An Ebola outbreak in the Democratic Republic of Congo has recorded a 66% fatality rate and the World Health Organisation has said the number of cases is likely to rise. Efforts to tackle the scourge are being hampered by disruption from armed militia groups. Misinformation about the outbreak is also hindering support. Wellcome Trust Head Jeremy Farrar said it was “remarkable” that the disease hadn't spread further but the numbers were “frightening” and their increase “terrifying”. Health officials now have a supply of Merck’s experimental V920 drug, which though effective, is in limited supply.